🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability

RecruitingNAAges any - 24 YearsAllUniversity Hospital, Brest
NCT07302048 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pain is described by patients with a Neurodevelopmental Disorder (NDD), including Autism Spectrum Disorder (ASD), Intellectual Development Disorder (IDD) or multiple disabilities, and the family as one of the main associated disorders; its management is also one of the main concerns of families and professionals. At present, there is no validated and tested pain management system in populations facing complex pain situations. In response to the lack of a pain management services, a multi-disciplinary mobile team was set up in September 2022 at the Brest University Hospital (Mobile Pain Handicap Team Intellectual Disability 0-25 years; MoDIDol). This team offers a specific protocol for the assessment and management of pain that takes into account the social and family environment, the living context and the clinical characteristics of patients (children, adolescents and young adults (0-25

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged from birth up to 24 years inclusive (i.e., under 25 years old) * Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or profound multiple disabilities, based on international classification systems (ICD-11 or DSM-5) * Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team * PGIC score ≥ 3 * Living in or receiving care in the departments of Finistère, Côtes-d'Armor, or Morbihan * Written informed consent provided by parents, legal guardians, or holders of parental authority, authorizing data collection for research and publication purposes * Affiliated with or benefiting from a French national health insurance scheme Exclusion Criteria: * More than three places of residence and/or care settings * Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires
💊

What it tests

  • MoDIDol intervention
📍

Where

1 site
CHU de Brest - Hôpital Morvan
Brest, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy